Acadia To Present At The 34th Annual J.P. Morgan Healthcare Conference On January 12, 2016

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced that it will present at the 34th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016, at 11:30 a.m. Pacific Time in San Francisco.

Back to news